Volume 101, Issue 4, Pages (May 2000)

Slides:



Advertisements
Similar presentations
Volume 8, Issue 12, Pages (December 2000)
Advertisements

Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 9, Issue 2, Pages (February 2002)
Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA
Volume 11, Issue 3, Pages (March 2003)
Tsan Xiao, Par Towb, Steven A. Wasserman, Stephen R. Sprang  Cell 
Crystal Structure of M. tuberculosis ABC Phosphate Transport Receptor
Volume 11, Issue 6, Pages (June 2003)
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 124, Issue 1, Pages (January 2006)
Modular Recognition of RNA by a Human Pumilio-Homology Domain
Volume 31, Issue 1, Pages (July 2009)
Chaperone-Assisted Crystallography with DARPins
Tom Huxford, De-Bin Huang, Shiva Malek, Gourisankar Ghosh  Cell 
Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis  John J.G. Tesmer, David M. Berman, Alfred G.
Volume 10, Issue 12, Pages (December 2002)
Volume 130, Issue 6, Pages (September 2007)
Einav Gross, David B Kastner, Chris A Kaiser, Deborah Fass  Cell 
Volume 6, Issue 3, Pages (September 2000)
David R Buckler, Yuchen Zhou, Ann M Stock  Structure 
Volume 6, Issue 12, Pages (December 1998)
Crystal Structure of the MHC Class I Homolog MIC-A, a γδ T Cell Ligand
Crystal Structure of the Human High-Affinity IgE Receptor
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 4, Issue 5, Pages (November 1999)
Hong Ye, Young Chul Park, Mara Kreishman, Elliott Kieff, Hao Wu 
Crystal Structure of Recombinant Human Interleukin-22
Volume 11, Issue 6, Pages (June 2003)
Volume 124, Issue 5, Pages (March 2006)
Structure of the Cathelicidin Motif of Protegrin-3 Precursor
Moosa Mohammadi, Joseph Schlessinger, Stevan R Hubbard  Cell 
Andrew H. Huber, W.James Nelson, William I. Weis  Cell 
The Crystal Structure of the Costimulatory OX40-OX40L Complex
Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains  Beth A. Wurzburg, Scott C. Garman, Theodore.
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Volume 91, Issue 5, Pages (November 1997)
Yi Mo, Benjamin Vaessen, Karen Johnston, Ronen Marmorstein 
Volume 6, Issue 6, Pages (December 2000)
Volume 91, Issue 7, Pages (December 1997)
ICAT Inhibits β-Catenin Binding to Tcf/Lef-Family Transcription Factors and the General Coactivator p300 Using Independent Structural Modules  Danette.
A Putative Mechanism for Downregulation of the Catalytic Activity of the EGF Receptor via Direct Contact between Its Kinase and C-Terminal Domains  Meytal.
Structural Basis for FGF Receptor Dimerization and Activation
Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 15, Issue 6, Pages (December 2001)
Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer 
Volume 11, Issue 3, Pages (March 2003)
Volume 11, Issue 2, Pages (February 2003)
Tertiary Structure of Destrin and Structural Similarity between Two Actin-Regulating Protein Families  H Hatanaka, K Ogura, K Moriyama, S Ichikawa, I.
Solution Structure of a TBP–TAFII230 Complex
Volume 130, Issue 6, Pages (September 2007)
Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
Volume 91, Issue 5, Pages (November 1997)
Volume 5, Issue 10, Pages (October 1997)
Hideki Kusunoki, Ruby I MacDonald, Alfonso Mondragón  Structure 
Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency  Shannon.
Pingwei Li, Gerry McDermott, Roland K. Strong  Immunity 
Structure of the InlB Leucine-Rich Repeats, a Domain that Triggers Host Cell Invasion by the Bacterial Pathogen L. monocytogenes  Michael Marino, Laurence.
Structure of CD94 Reveals a Novel C-Type Lectin Fold
Peter König, Rafael Giraldo, Lynda Chapman, Daniela Rhodes  Cell 
Structure of an IκBα/NF-κB Complex
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of the Histone Acetyltransferase Hat1
The Structure of Sortase B, a Cysteine Transpeptidase that Tethers Surface Protein to the Staphylococcus aureus Cell Wall  Yinong Zong, Sarkis K Mazmanian,
Sabine Pokutta, William I. Weis  Molecular Cell 
The Crystal Structure of an Unusual Processivity Factor, Herpes Simplex Virus UL42, Bound to the C Terminus of Its Cognate Polymerase  Harmon J Zuccola,
Structural Basis for Activation of ARF GTPase
Morgan Huse, Ye-Guang Chen, Joan Massagué, John Kuriyan  Cell 
Presentation transcript:

Volume 101, Issue 4, Pages 413-424 (May 2000) Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand- Receptor Specificity  Alexander N Plotnikov, Stevan R Hubbard, Joseph Schlessinger, Moosa Mohammadi  Cell  Volume 101, Issue 4, Pages 413-424 (May 2000) DOI: 10.1016/S0092-8674(00)80851-X

Figure 1 Ribbon Diagrams of the FGF1-FGFR1 and FGF2-FGFR2 Complexes The Ig-like domains 2 (D2) and 3 (D3) are shown in green and cyan, respectively. The short linker that connects D2 and D3 is colored gray. FGF1 and FGF2 are shown in orange. The secondary structure assignments for FGFR1 and FGFR2 were obtained with the program PROCHECK (Laskowski et al. 1993). The β strands for D2 and D3 are labeled according to the strand nomenclature for the canonical I-set member telokin. The helix between βA and βA′, gA, is a 310 helix. In both FGF1-FGFR1 and FGF2-FGFR2 structures, the βC-βC′ loops in D3 are disordered. In addition, most of the segment between βC′ and βE in D3 of FGF1-FGFR1 is disordered as well. In the FGF2-FGFR2 structure, this segment is well ordered and is colored purple. The amino and carboxy termini are denoted by NT and CT. The disulfide bonds in D2 and D3 are shown in ball-and-stick rendering with sulfur atoms colored yellow. The β strands of FGF1 are labeled from 1 to 12 according to published nomenclature (Faham et al. 1998). This figure was created using the programs Molscript (Kraulis 1991) and Raster3D (Merrit and Bacon 1997). Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)

Figure 2 Space-Filling Models of the FGF1-FGFR1 and FGF2-FGFR2 Complexes The coloring for D2, D3, the linker, and FGFs is the same as in Figure 1. The view is the same as in Figure 1. To better visualize the binding interfaces on FGFs and on FGFRs, the molecules are pulled away from each other and rotated 90° about the vertical axis as indicated (left and right panels). Residues in FGF1 and FGF2 are colored with respect to the FGFR regions with which they interact. FGF1 and FGF2 residues that interact with D2 are colored green, residues that interact with the linker region are colored gray, and residues that interact with D3 are colored cyan. FGF2 residues that interact with the βC′-βE segment (shown in purple) of FGFR2 are colored red. The residues in FGFR1 and FGFR2 that interact with FGF1 and FGF2, respectively, are colored orange. In addition, in the FGF2-FGFR2 structure, receptor residues in the βC′-βE segment that contact FGF2 are in red. Ligand and receptor residues are considered to be in the FGF-FGFR interface if at least one pair of atoms (side chain or main chain) has an interatomic distance of 3.8 Å or less. This figure was created using the programs Molscript and Raster3D. Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)

Figure 3 Detailed Interactions between FGF and FGFR in the FGF-D2 and FGF-Linker Interfaces (A) Stereo view of the hydrophobic interface between FGF2 and D2 of FGFR2. (B) Stereo view of the hydrophobic interface between FGF1 and D2 of FGFR1. (C) Stereo view of the conserved network of hydrogen bonds between FGF2 and FGFR2 in the vicinity of Arg-251 in the D2-D3 linker. (D) Stereo view of the network of hydrogen bonds between FGF1 and FGFR1 in the vicinity of Arg-250 in the D2-D3 linker. Only side chains of interacting residues are shown. At the right side of each stereo pair, a view of the whole structure in the exact orientation as in stereo views is shown, and the region of interest is highlighted. Color coding is the same as in Figure 1: FGF1 and FGF2 in orange, D2 in green, D3 in cyan, and the linker in gray. Oxygen atoms are colored red, nitrogen atoms blue, and carbon atoms have the same coloring as the molecules to which they belong. Dotted lines represent hydrogen bonds. This figure was created using the programs Molscript and Raster3D. Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)

Figure 6 Structure-Based Sequence Alignment of FGFs Sequence alignment was performed using the CLUSTALW program (Thompson et al. 1994). All of the FGFs used in this alignment are from human, with the exception of FGF15, for which only the mouse sequence is available. The secondary structure assignment is according to the published nomenclature, with the β strands labeled from 1 through 12 (Faham et al. 1998). The location and the length of the β strands are shown on the top of the sequence alignment. FGF residues are colored with respect to the region on FGFR with which they interact: FGF residues that interact with D2 are colored green, residues that interact with the linker region are colored gray, and residues that interact with D3 are colored cyan. FGF residues that interact with the βC′-βE segment in D3 are colored red. A period indicates sequence identity to FGF2. A dash represents a gap introduced to optimize the alignment. A tilde at the C-terminal end of an FGF sequence indicates that the sequence is truncated. A star indicates that numbering does not start at the initiation methionine. Residue numbering for FGF1 and FGF2 is according to Zhu et al. 1991 and Springer et al. 1994, respectively. FGF residues shown by mutagenesis to be important for receptor binding are checkmarked. Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)

Figure 5 Structure-Based Sequence Alignment of the Ligand Binding Domains of Human FGF Receptors (A) Structure-based sequence alignment of D2 and D2-D3 linker. (B) Structure-based sequence alignment of D3. The secondary structure assignment for FGFR2 was obtained using the program PROCHECK (Laskowski et al. 1993). The location and length of the strands and helices are shown on the top of the sequence alignment. The letter “g” denotes a residue in a 310 helix. Only 310 helices comprising four or more residues are indicated. A period indicates sequence identity to FGFR2. A dash represents a gap introduced to optimize the alignment. FGFR residues that interact with FGF2 are colored yellow. FGFR residues in the βC′-βE segment that contact FGF2 are in red. Only receptor residues whose side chain or main chain atoms are within 3.8 Å of FGF2 are colored. Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)

Figure 4 Detailed Interactions between FGF and FGFR in the FGF-D3 Interfaces (A) Stereo view of the interface between FGF2 and the βF-βG loop of D3 in the FGF2-FGFR2 structure. (B) Stereo view of the interface between N-terminal sequences (prior to β1) of FGF2 and D3 in the FGF2-FGFR2 structure. (C) Stereo view of the interface between FGF2 and the βC′-βE segment (shown in purple) of D3 in the FGF2-FGFR2 structure. (D) Stereo view of the interface between FGF1 and D3 in the FGF1-FGFR1 structure. At the right side of each stereo pair, a view of the whole structure in the exact orientation as in stereo views is shown, and the region of interest is highlighted. Only side chains of interacting residues are shown. Color coding is the same as in Figure 3. Dotted lines represent hydrogen bonds. This figure was created using the programs Molscript and Raster3D. Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)

Figure 7 FGFR Mutations Implicated in Human Skeletal Disorders The locations of the mutations in the human FGFR2 gene that lead to skeletal disorders are mapped onto a ribbon representation the FGF2-FGFR2 structure. Side chains of the residues are colored with respect to the type of substitution. In yellow are mutations that substitute a cysteine with another amino acid or vice versa, resulting in the creation of unpaired cysteines. In red are mutations that are expected to destabilize the tertiary structure of D3 and thus disfavor the formation of the correct intradomain disulfide bridge. In green are mutations that are predicted to affect ligand binding affinity or specificity. This figure was created using the programs Molscript and Raster3D. Cell 2000 101, 413-424DOI: (10.1016/S0092-8674(00)80851-X)